Apigene
PrivateLast Round
Pre Seed
Jun 24, 2024
Total Funding Raised
$500,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Apigene operates in AI, Data & Cloud Infrastructure and is based in Tel Aviv. Its latest recorded funding round was a Pre Seed round in June 2024.
Apigene is an enterprise software company that provides a runtime layer for connecting AI agents to APIs and Model Context Protocol (MCP) servers.
Sector
AI, Data & Cloud Infrastructure
Verticals
API Management, Workflow Automation, NLP & Conversational AI, Data Governance, Low-Code/No-Code
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apigene Comparables
Compare Apigene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MintMCP | 87% | |
| Manufact | 86% | |
| Arcade.dev | 77% |
For institutional investors. Book with your work email.
Apigene Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Apigene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Varana Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 58% MoM, reaching 6.4K.
- Jul 26, 2026
Monthly visitors increased 62% MoM.
For institutional investors. Book with your work email.
Apigene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Apigene's valuation, stock price, and market status.
Is Apigene a public or private company?
Apigene is a private company.
What is the current stock price of Apigene?
Apigene is a private company, so its shares have no public market price. Caplight tracks Apigene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Apigene worth (valuation)?
Valuation information for Apigene is not publicly available.
Can I buy Apigene stock?
Apigene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Apigene's last funding round?
Apigene's most recent funding round was Pre Seed on June 24, 2024.
Who are the main investors in Apigene?
Key investors in Apigene include Varana Capital.
Will Apigene IPO soon?
No public IPO plans have been announced for Apigene.
How can I track Apigene secondary market activity?
Caplight tracks bids, offers, and trades in Apigene's shares on secondary markets.